FilingSEC EDGAR6-K
Cardiol Therapeutics discloses past service and development agreements.
· SEC accepted
StageAgreement
Filing content
Cardiol Therapeutics has disclosed the details of its master services agreement and development agreement entered into in 2017 and 2018.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…